Back

Risk of Suicide Ideation in Comorbid Substance Use Disorder and Major Depression.

Onaemo, V.; Fawehinmi, T. O.; DArcy, C.

2022-03-01 addiction medicine
10.1101/2022.02.28.22271669
Show abstract

BackgroundSuicidal behaviour is commonly associated with major depression (MD) and substance use disorders (SUDs). However, there is a paucity of research on risk for suicide ideation among individuals with comorbid SUDs and MD in the general population. ObjectivesThis study investigated the associated risk of suicide ideation in comorbid SUDs - cannabis use disorder (CUD), alcohol use disorder (AUD), drug use disorder (DUD) with depression in a nationally representative sample. MethodsMultilevel logistic regression models were used to analyze the 2012 Canadian Community Health Survey (CCHS-MHC) data. This is a cross-sectional survey of nationally representative samples of Canadians (n = 25,113) aged 15 years and older residing in the ten Canadian provinces between January and December 2012. Diagnoses of MD episode, AUD, DUD, CUD, and suicide risk were based on the WHO-CIDI-3.0 derived from DSM-IV diagnostic criteria. ResultsComorbidity was found to be the strongest predictor of suicide ideation. Compared to those with no diagnosis, individuals with a comorbid diagnosis of AUD with MDE, CUD with MDE, or DUD with MDE were 9 to 16 times more likely to have suicide ideation. A diagnosis of MDE was a significant predictor of suicide ideation with about a 7-fold increased risk. ConclusionSuicide is a preventable public health issue. Our study found a significantly increased risk of suicide ideation among persons who have comorbid SUD with MD. Effective integration of mental health and addictions services could mitigate the risk of suicide and contribute to better outcomes.

Matching journals

1
Drug and Alcohol Dependence
Elsevier BV · based on 21 published papers
Top 0.2%
136× avg
2
Addiction
Wiley · based on 24 published papers
Top 0.3%
82× avg
3
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 44%
11.3%
4
The British Journal of Psychiatry
Royal College of Psychiatrists · based on 21 published papers
Top 0.1%
82× avg
5
International Journal of Drug Policy
Elsevier BV · based on 11 published papers
Top 0.2%
143× avg
6
American Journal of Psychiatry
American Psychiatric Association Publishing · based on 14 published papers
#1
117× avg
7
JAMA Network Open
American Medical Association (AMA) · based on 125 published papers
Top 3%
7.4× avg
8
Frontiers in Psychiatry
Frontiers Media SA · based on 56 published papers
Top 2%
15× avg
9
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 4%
8.8× avg
10
Addiction Biology
Wiley · based on 13 published papers
Top 0.5%
35× avg
11
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 1%
21× avg
12
International Journal of Environmental Research and Public Health
MDPI AG · based on 116 published papers
Top 11%
2.7× avg
13
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Elsevier BV · based on 10 published papers
Top 0.5%
24× avg
14
Brain Stimulation
Elsevier BV · based on 27 published papers
Top 3%
5.6× avg
15
Biological Psychiatry
Elsevier BV · based on 36 published papers
Top 5%
2.9× avg